ECT denied as duplicate or overlapping therapy by Cigna?

Cigna's specific coverage criteria for ect are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna May Deny Electroconvulsive Therapy (ECT) as Duplicate Therapy

Electroconvulsive therapy is a well-established psychiatric procedure used for severe, treatment-resistant depression and certain other serious mental health conditions. A "duplicate therapy" denial from Cigna typically means the plan has determined that another treatment already being received — most commonly a psychotropic medication or another somatic therapy — addresses the same clinical indication, making ECT redundant in the plan's view.

## Why This Denial Is Appealable

ECT is not interchangeable with medication management or talk therapy. Its mechanism of action is distinct, its clinical indications are specific (particularly treatment-resistant or severe cases), and leading psychiatric organizations recognize ECT as a separate, non-duplicative intervention. A duplicate-therapy denial for ECT frequently reflects a formulaic claims-processing decision rather than an individualized clinical review. Under ERISA §503 and ACA §2719, the plan must conduct a full-and-fair review that considers your specific clinical circumstances. The Mental Health Parity and Addiction Equity Act (MHPAEA) also applies: Cigna cannot impose restrictions on mental health treatments that would not be applied to comparable medical or surgical treatments.

## Federal Appeal Framework

• Internal appeal: File within the deadline on your denial notice. Request all clinical criteria and utilization-management guidelines Cigna applied to this determination.
• External review: Available after final internal denial or if Cigna fails to decide within the regulatory timeframe. The standard external-review window is approximately four months from the final adverse determination. Expedited review is available — and often appropriate for ECT — when delay would seriously jeopardize health or the ability to regain functioning.

## Concrete Appeal Steps

1. Obtain Cigna's medical coverage policy for ECT and identify exactly what criteria were used to classify it as duplicative. 2. Have your treating psychiatrist document in writing why ECT is not duplicative of current treatment — specifically what ECT achieves that the existing treatment does not. 3. Request that Cigna identify which specific treatment it considers duplicative and produce the clinical basis for that equivalence claim. 4. Raise MHPAEA: ask Cigna to identify any comparable medical or surgical procedure for which it applies a "duplicate therapy" bar alongside ongoing treatment. 5. Submit the appeal with the psychiatrist's letter, treatment history, and a MHPAEA comparability challenge if applicable.

## Documentation to Gather

• Diagnosis confirmation: Psychiatric evaluation notes establishing the diagnosis, severity, and chronicity of the condition.
• Prior-treatment history: A complete, dated list of all medications and therapies tried, with documented outcomes — including any partial responses, intolerances, or treatment failures.
• Clinical severity: Psychiatrist documentation of current functional impairment, risk assessment (including any safety concerns), and the clinical rationale for recommending ECT at this time.
• Prescriber medical-necessity letter: A letter from the treating psychiatrist explaining why ECT is the appropriate next intervention and why it is not duplicative of any treatment currently being received.
• Relevant guideline reference: A note referencing the applicable guideline organization (such as the American Psychiatric Association) and that organization's characterization of ECT's appropriate role.

## Criteria-Mapping Structure

Request Cigna's ECT coverage criteria and duplicate-therapy definition. Create a table mapping each criterion to specific chart evidence. For the duplicate-therapy claim specifically, have your psychiatrist directly address the mechanism, indication, and expected outcome difference between ECT and the treatment Cigna identified as equivalent.